TG Therapeutics, Inc.
TG Therapeutics, Inc.（TGTX）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
tgtx · 股价预测 · 13 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 13 位华尔街分析师
Buy
13 位分析师
共识
评级分布
12 个月目标价
High
$70.00
Consensus
$54.50
+32.2% upside
Low
$39.00
Median: $54.5 · Last Close: $41.22
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$54.50
32.2% upside
High Target
$70
69.8%
Low Target
$39
-5.4%
Current Price
$41.22
as of today
Based on analyst price targets, the TGTX stock price prediction for the next 12 months ranges from $39 to $70. The consensus TGTX price forecast of $54.50 implies 32.2% upside from the current price of $41.22.
短期股价预测
Bull算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $41.07 | ↓ 0.36% |
1-day model range: $40.77–$41.37. Peak: $41.37 (-0.36%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $52 | +25.8% |
| 2028 | $60 | +45.2% |
| 2029 | $65 | +58.7% |
| 2030 | $69 | +67.5% |
| 2031 | — | +73.1% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · TGTX · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-27 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-05-06 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-02-02 | JP Morgan | Maintains | Overweight→Overweight |
| 2026-01-15 | Goldman Sachs | Maintains | Neutral→Neutral |
| 2025-11-03 | JP Morgan | Maintains | Overweight→Overweight |
| 2025-09-17 | B. Riley Securities | Maintains | Buy→Buy |
| 2025-03-04 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-01-15 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-11-25 | JP Morgan | Maintains | Overweight→Overweight |
| 2024-11-05 | Goldman Sachs | Maintains | Neutral→Neutral |
Wall Street analysts have recently issued updated ratings on TG Therapeutics, Inc. (TGTX) stock. Of the recent 81 rating actions, 1 were upgrades and 2 were downgrades. 13 analysts currently cover TGTX.
分析师推荐趋势
TGTX analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 2 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$941M
↓ 41.3% YoY
Revenue Next Year
$1.2B
↑ 31.7% YoY
EPS This Year
$1.38
EPS Next Year
$2.53
↑ 83.5% YoY
EPS ForecastReported vs Estimated
Analysts forecast TGTX EPS of $1.38 for the current fiscal year, based on estimates from 5 analysts. The TGTX revenue forecast is $941M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
TGTX 股价预测由两类独立数据源支撑：来自 13 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。TGTX 的共识目标价为 $54.50（+32.2% 上行空间），分析师共识为 Buy。
TGTX 的短期预测（明日）为 $41.07（-0.36%）。 TGTX 对 2027 年的股价预测均值为 $52。 TGTX 对 2030 年的预测区间为 $64–$75。
TG Therapeutics, Inc. 在 NASDAQ 上市，代码 TGTX。TGTX 在 2027 年的整体展望偏积极，在覆盖分析师中约 85% 对应 Buy 共识。
常见问题
TGTX 预测 · 8 个问题根据 13 位华尔街分析师，TGTX 的 12 个月平均目标价为 $54.50，最高 $70.00、最低 $39.00。若有图表，中位目标价可在上方查看。相对当前价 $41.22，隐含约 +32.2% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.